Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
29.1M
-
Number of holders
-
105
-
Total 13F shares, excl. options
-
14.1M
-
Shares change
-
+2.59M
-
Total reported value, excl. options
-
$582M
-
Value change
-
+$106M
-
Put/Call ratio
-
1.06
-
Number of buys
-
75
-
Number of sells
-
-32
-
Price
-
$41.42
Significant Holders of Krystal Biotech, Inc. - COMMON STOCK (KRYS) as of Q2 2020
119 filings reported holding KRYS - Krystal Biotech, Inc. - COMMON STOCK as of Q2 2020.
Krystal Biotech, Inc. - COMMON STOCK (KRYS) has 105 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.1M shares
of 29.1M outstanding shares and own 48.36% of the company stock.
Largest 10 shareholders include Redmile Group, LLC (1.41M shares), FMR LLC (1.33M shares), BlackRock Inc. (1.11M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.02M shares), FRAZIER MANAGEMENT LLC (895K shares), BAKER BROS. ADVISORS LP (818K shares), VANGUARD GROUP INC (725K shares), STATE STREET CORP (695K shares), CREDIT SUISSE AG/ (683K shares), and Point72 Asset Management, L.P. (539K shares).
This table shows the top 105 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.